Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I.

[1]  Stefan Blankenberg,et al.  Sensitive troponin I assay in early diagnosis of acute myocardial infarction. , 2009, The New England journal of medicine.

[2]  D. Morrow.  Clinical application of sensitive troponin assays. , 2009, The New England journal of medicine.

[3]  Tobias Reichlin,et al.  Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. , 2009, The New England journal of medicine.

[4]  M. Sabatine,et al.  Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial. , 2009, American heart journal.

[5]  P. Jarolim,et al.  Implementation of a highly sensitive cardiac troponin I assay: test volumes, positivity rates and interpretation of results. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[6]  M. Sabatine,et al.  Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. , 2008, European heart journal.

[7]  F. Apple,et al.  Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. , 2008, Clinical chemistry.

[8]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[9]  Jeroen J. Bax,et al.  Universal definition of myocardial infarction. , 2007 .

[10]  J. Ornato,et al.  ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie , 2007, Journal of the American College of Cardiology.

[11]  D. Morrow,et al.  Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. , 2007, American journal of clinical pathology.

[12]  A. Skene,et al.  Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. , 2007, JAMA.

[13]  Fred S Apple,et al.  National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. , 2007, Circulation.

[14]  A. Wu,et al.  Development and preliminary clinical validation of a high sensitivity assay for cardiac troponin using a capillary flow (single molecule) fluorescence detector. , 2006, Clinical chemistry.

[15]  A. Jaffe,et al.  Importance of low concentrations of cardiac troponins. , 2006, Clinical chemistry.

[16]  A. Skene,et al.  Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial. , 2006, American heart journal.

[17]  A. Khera,et al.  Prevalence and Determinants of Troponin T Elevation in the General Population , 2006, Circulation.

[18]  P. Venge,et al.  Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Year-Old Men: A Community-Based Cohort Study , 2006, Circulation.

[19]  Joseph P Ornato,et al.  Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients. , 2004, Journal of the American College of Cardiology.

[20]  R. Califf,et al.  Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. , 2003, Journal of the American College of Cardiology.

[21]  Carl J Pepine,et al.  ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients , 2002, Circulation.

[22]  A. Go,et al.  The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. , 2001, Journal of the American College of Cardiology.

[23]  A. Jaffe,et al.  It's time for a change to a troponin standard. , 2000, Circulation.

[24]  E. Antman,et al.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. , 2000, JAMA.

[25]  D Wybenga,et al.  Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. , 1996, The New England journal of medicine.

[26]  G. Bergandi,et al.  [Cardiac troponin I in unstable angina]. , 1996, Minerva cardioangiologica.

[27]  M. Bissell,et al.  Value of Cardiac Troponin I Cutoff Concentrations below the 99th Percentile for Clinical Decision-Making , 2010 .

[28]  A. Jaffe,et al.  Specificity of a high-sensitivity cardiac troponin I assay using single-molecule-counting technology. , 2009, Clinical chemistry.

[29]  E. Antman,et al.  Evaluation of high-sensitivity assays for cardiac troponin. , 2009, Clinical chemistry.

[30]  A. Wu,et al.  Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. , 2009, Clinical chemistry.

[31]  Fred S Apple,et al.  Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome. , 2009, Clinical chemistry.